As a leader in the areas of digital, AI and life sciences, Dan partners with clients to realize value at the intersection of technology and customer needs. He also leads ZS’s engagement with client CMOs to enhance commercial strategy across organizations.

Since 2014, Dan has worked in the pharma and biotech sector at ZS, leveraging a foundation built upon analytics, research and strategy. He collaborates with clients to create solutions that specifically meet their needs.
 

Dan has helped many of the top global pharmaceutical, biotech and healthcare companies develop and implement commercial strategies. All his work across the healthcare ecosystem is in service of improving global patient outcomes. Dan also leads ZS's partnership with World Economic Forum on AI in healthcare, where he’s responsible for translating research with private-sector executives and public-sector leaders into actionable proposals for scaling healthcare AI.

Before joining ZS, Dan spent five years as a brand marketer at a $100B financial services organization, developing and promoting mutual funds, hedge funds and exchange traded funds.

Dan holds an MBA from the UCLA Anderson School of Management and a bachelor’s in fine arts from New York University.